| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027036062 |
| P356 | DOI | 10.1186/1471-2202-6-61 |
| P932 | PMC publication ID | 1249579 |
| P698 | PubMed publication ID | 16188027 |
| P5875 | ResearchGate publication ID | 7576493 |
| P50 | author | Damir Janigro | Q37378626 |
| P2093 | author name string | Luca Cucullo | |
| Sanjay Awasthi | |||
| Yogesh C Awasthi | |||
| Vince Fazio | |||
| Sharad S Singhal | |||
| Gabriele Dini | |||
| Kerri L Hallene | |||
| P2860 | cites work | Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin | Q22254720 |
| RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes | Q24291401 | ||
| Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographic-histopathologic correlations | Q48390144 | ||
| Focal cortical dysplasias in eloquent cortex: functional characteristics and correlation with MRI and histopathologic changes | Q48669501 | ||
| Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. | Q48669608 | ||
| Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. | Q53859498 | ||
| Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity | Q24337472 | ||
| Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases | Q24651430 | ||
| Significance of MDR1 and multiple drug resistance in refractory human epileptic brain | Q24804381 | ||
| RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis | Q28141762 | ||
| Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76 | Q28182524 | ||
| Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity | Q28182550 | ||
| Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells | Q28203126 | ||
| RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis | Q28207629 | ||
| Purification and functional reconstitution of intact ral-binding Gtpase activating protein, RLIP76, in artificial liposomes | Q28208524 | ||
| Carbamazepine is not a substrate for P-glycoprotein | Q28363548 | ||
| A putative effector of Ral has homology to Rho/Rac GTPase activating proteins | Q28512740 | ||
| Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus | Q28579981 | ||
| Interaction of antiepileptic drugs with human P-glycoprotein in vitro | Q31155945 | ||
| P-Glycoprotein, a gatekeeper in the blood-brain barrier | Q33904245 | ||
| ABC transporters and the blood-brain barrier | Q33978165 | ||
| POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis | Q34393707 | ||
| Drug resistance in epilepsy: the role of the blood-brain barrier | Q34624873 | ||
| The problem of the drug-resistant epilepsies | Q34624880 | ||
| Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76). | Q35052499 | ||
| Mechanisms of antiepileptic drug resistance | Q35088259 | ||
| Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy | Q35109033 | ||
| Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance | Q35179100 | ||
| Role of 4-hydroxynonenal in stress-mediated apoptosis signaling | Q35189540 | ||
| Potential role of drug transporters in the pathogenesis of medically intractable epilepsy | Q36023613 | ||
| P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs | Q37355653 | ||
| The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model | Q38448723 | ||
| RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. | Q40459619 | ||
| RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance | Q40512245 | ||
| The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein | Q42031200 | ||
| P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain | Q43815938 | ||
| Functional reconstitution of Ral-binding GTPase activating protein, RLIP76, in proteoliposomes catalyzing ATP-dependent transport of glutathione conjugate of 4-hydroxynonenal. | Q44209469 | ||
| Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity | Q44381534 | ||
| Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells | Q46551004 | ||
| RLIP76 is a major determinant of radiation sensitivity | Q46604639 | ||
| Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytes | Q48168333 | ||
| Dynamic in vitro model of the blood-brain barrier. Gene profiling using cDNA microarray analysis | Q48206066 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug resistance | Q12147416 |
| P304 | page(s) | 61 | |
| P577 | publication date | 2005-09-27 | |
| P1433 | published in | BMC Neuroscience | Q15766477 |
| P1476 | title | RLIP76, a non-ABC transporter, and drug resistance in epilepsy | |
| P478 | volume | 6 |
| Q28538154 | Amelioration of cancer stem cells in macrophage colony stimulating factor-expressing U87MG-human glioblastoma upon 5-fluorouracil therapy |
| Q30481778 | Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis |
| Q37875183 | Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases. |
| Q37104987 | CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents |
| Q36341748 | Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy |
| Q38178326 | Development of individualized medicine for epilepsy based on genetic information |
| Q33997439 | Drug delivery to brain tumours: challenges and progress |
| Q37362486 | Drug interactions at the blood-brain barrier: fact or fantasy? |
| Q37900131 | Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective. |
| Q36555922 | Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications |
| Q35351642 | Genetic polymorphism of drug refractory epilepsy |
| Q35787969 | Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells. |
| Q39215770 | Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells |
| Q30361123 | Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. |
| Q47177557 | Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia. |
| Q36895830 | Multidrug resistance in epilepsy: a pharmacogenomic update |
| Q39752034 | Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow |
| Q42157342 | PharmGKB summary: carbamazepine pathway |
| Q38544300 | Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions |
| Q37698426 | Physiological and pharmacological significance of glutathione-conjugate transport |
| Q34237989 | Polymorphism of ABCB1/MDR1 C3435T in children and adolescents with partial epilepsy is due to different criteria for drug resistance - preliminary results |
| Q37181571 | RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients |
| Q37217140 | RLIP76 and Cancer |
| Q33867008 | RLIP76: a versatile transporter and an emerging target for cancer therapy |
| Q45884490 | RNAi inhibits Coriaria lactone-induced MDR1b overexpression in rat brain microvascular endothelial cells |
| Q46845981 | The association between polymorphisms in RLIP76 and drug response in epilepsy |
| Q42524620 | White matter angiopathy is common in pediatric patients with intractable focal epilepsies |
Search more.